cullin 7
Zuletzt aktualisiert 18. Aug 2020
Erfüllt die redaktionelle Richtlinien
- HerunterladenHerunterladen
- Teilen
- Language
- Diskussion
- Ask Patient
- Audio-Version
- Zu bevorzugten Quellen bei Google hinzufügen
Der CUL7 gene provides instructions for making a protein called cullin-7. This protein plays a role in the ubiquitin-proteasome system, which is the cell machinery that breaks down (degrades) unwanted proteins.
Normal function
Der CUL7 gene provides instructions for making a protein called cullin-7. This protein plays a role in the ubiquitin-proteasome system, which is the cell machinery that breaks down (degrades) unwanted proteins.
Cullin-7 helps assemble a complex known as an E3 ubiquitin ligase. This complex tags damaged and excess proteins with molecules called ubiquitin. Ubiquitin serves as a signal to specialized cell structures known as proteasomes, which attach (bind) to the tagged proteins and degrade them. The ubiquitin-proteasome system acts as the cell's quality control system by disposing of damaged, misshapen, and excess proteins. This system also regulates the level of proteins involved in several critical cell activities such as the timing of cell division and growth. In particular, cullin-7 is thought to help regulate proteins involved in the body's response to growth hormones, although its specific role in this process is unknown.
Conditions referring to this gene or chromosome
Other names
CUL7_HUMAN
dJ20C7.5
KIAA0076
Related patient information and medicines

Patient information leaflet
Impfung gegen Grippe
Getting the flu vaccine is a safe and effective way to protect against becoming seriously ill with flu. What is the flu jab for. Influenza (flu) Flu ist a common viral infection that tends to be most common in the winter. Flu can cause much more severe symptoms than the common cold Common cold. Some people can become seriously ill with flu, needing.

Patient information leaflet
Vorbeugung und Behandlung von bakterieller Vaginose
These are clinda. Tinidazole i... If you have persistent BV (i.e. it does not settle down with the first treatment you try) then your doctor may want to take further vaginal swabs to check whether there is another cause of the discharge. They may also suggest the following treatments: Metronidazol They will usually suggest that you use the.

Patient information leaflet
Herpesbläschen
About 1 in 5 people in the UK have recurring cold sores. What are cold sores? | Patient Explainers About 1 in 5 people in the UK have recurring cold sores. ...patient.info/) Facebook: [https://www.facebook.com/patient](https://www.facebook.com/patient) Twitter: [https://twitter.com/patient](https://twitter.com/patient) Pinterest:.

Patient information leaflet
Medikament gegen Bettnässen - Desmopressin
Desmopressin is the medicine most commonly used to treat bedwetting. It can be used both short-term (for example, for a school trip or a sleepover) or long-term. What is desmopressin. ... Do not give desmopressin to a child who has diarrhoea or is being sick (vomiting) until the illness has passed and your child is well. Further information about.

Patient information leaflet
Bettnässen
(A permanent cure following treat... Desmopressin can also be useful for short spells of time. For example, during holidays or for times away from home. See the separate leaflet called Bedwetting Medicine (Desmopressin) for more details Bedwetting medicine - desmopressin. Occasionally other medicines are used by specialists. Imipramine Imipramine.

Patient information leaflet
Koarktation der Aorta
Koarktation der Aorta is a type of angeborene Herzkrankheit where there is a narrowing in part of the aorta, the main artery that leaves the left side of the heart. Normal heart detail Cross-section diagram of a normal heart PatientPicksPlaceholder Heart - lung circulation heart - lung circulation What is coarctation of the aorta. Congenital.
Weiterführende Lektüre und Referenzen
- cullin 7; MedlinePlus, National Library of Medicine.
- Akilapa R, Irving M, Holder-Espinasse M. 3-M Syndrome. 2002 Mar 25 [updated 2025 Feb 27]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1481/
- Clayton PE, Hanson D, Magee L, Murray PG, Saunders E, Abu-Amero SN, Moore GE, Black GC. Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination. Clin Endocrinol (Oxf). 2012 Sep;77(3):335-42. doi: 10.1111/j.1365-2265.2012.04428.x.
- Hanson D, Murray PG, Black GC, Clayton PE. The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway. Horm Res Paediatr. 2011;76(6):369-78. doi: 10.1159/000334392. Epub 2011 Nov 29.
- Hanson D, Murray PG, Coulson T, Sud A, Omokanye A, Stratta E, Sakhinia F, Bonshek C, Wilson LC, Wakeling E, Temtamy SA, Aglan M, Rosser EM, Mansour S, Carcavilla A, Nampoothiri S, Khan WI, Banerjee I, Chandler KE, Black GC, Clayton PE. Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. J Mol Endocrinol. 2012 Oct 30;49(3):267-75. doi: 10.1530/JME-12-0034. Print 2012 Dec.
- Huber C, Dias-Santagata D, Glaser A, O'Sullivan J, Brauner R, Wu K, Xu X, Pearce K, Wang R, Uzielli ML, Dagoneau N, Chemaitilly W, Superti-Furga A, Dos Santos H, Megarbane A, Morin G, Gillessen-Kaesbach G, Hennekam R, Van der Burgt I, Black GC, Clayton PE, Read A, Le Merrer M, Scambler PJ, Munnich A, Pan ZQ, Winter R, Cormier-Daire V. Identification of mutations in CUL7 in 3-M syndrome. Nat Genet. 2005 Oct;37(10):1119-24. doi: 10.1038/ng1628. Epub 2005 Sep 4.
- Maksimova N, Hara K, Miyashia A, Nikolaeva I, Shiga A, Nogovicina A, Sukhomyasova A, Argunov V, Shvedova A, Ikeuchi T, Nishizawa M, Kuwano R, Onodera O. Clinical, molecular and histopathological features of short stature syndrome with novel CUL7 mutation in Yakuts: new population isolate in Asia. J Med Genet. 2007 Dec;44(12):772-8. doi: 10.1136/jmg.2007.051979. Epub 2007 Aug 3.
Artikelverlauf
Artikel auch verfügbar in Englisch, Deutsch, Spanisch, Französisch, Italienisch, Portugiesisch, Hindi, Hebräisch, Arabisch, und Schwedisch.
18. Aug 2020 | Neueste Version
1. Jun 2018 | Ursprünglich veröffentlicht
Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.
Abonnieren Sie den Patienten-Newsletter
Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.
Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.

